Showing results (101-110 of 162) with videos related to

Sort By:
Pageof 17
Journal of Biotechnology|July 20, 2010
Large double copy vectors are functional but show a size-dependent decline in transduction efficiencyTomas J Bos, Elke De Bruyne, Sandra Van Lint, et al.
Frontiers in Immunology|November 30, 2023
RNA-sequencing based first choice of treatment and determination of risk in multiple myelomaMartina Emde-Rajaratnam, Susanne Beck, Vladimir Benes, et al.
Blood|December 14, 2002
Multiple myeloma tumor progression in the 5T2MM murine model is a multistage and dynamic process of differentiation, proliferation, invasion, and apoptosisKewal Asosingh, Hendrik De Raeve, Ivan Van Riet, et al.
Biochemical and Biophysical Research Communications|October 22, 2008
Geranylgeranyl transferase type II inhibition prevents myeloma bone diseaseMichelle A Lawson, Les Coulton, Frank H Ebetino, et al.
Oncotarget|March 31, 2016
Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapyInès Dufait, Els Van Valckenborgh, Eline Menu, et al.
Leukemia|March 15, 2018
Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?Song Xu, Kim De Veirman, Ann De Becker, et al.
Oncotarget|November 23, 2017
The therapeutic potential of cell cycle targeting in multiple myelomaAnke Maes, Eline Menu, Kim De Veirman, et al.
Hepatology (Baltimore, Md.)|December 4, 2009
Chronic administration of valproic acid inhibits activation of mouse hepatic stellate cells in vitro and in vivoInge Mannaerts, Nele R Nuytten, Vera Rogiers, et al.
Frontiers in Immunology|April 16, 2021
Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating PotentialKen Maes, Anna Mondino, Juan José Lasarte, et al.
The Journal of Pathology|March 10, 2016
Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppressionJinheng Wang, Kim De Veirman, Sylvia Faict, et al.
Pageof 17